OpenAI has announced its investment in Merge Labs, a neurotech startup founded by CEO Sam Altman, with a significant funding of $252 million from OpenAI, Bain Capital, Gabe Newell, and other investors. Merge Labs aims to develop brain-computer interfaces without the need for brain implants, leveraging molecules and deep-reaching modalities like ultrasound to create seamless interfaces between biology, devices, and AI.
AI will be a critical component in Merge’s technology, enhancing high-bandwidth interfaces with AI operating systems capable of interpreting intent, adapting to individuals, and functioning reliably even with limited and noisy signals. OpenAI’s collaboration with Merge Labs will focus on developing scientific foundation models and cutting-edge tools to expedite progress in this domain.
Another notable player in the brain-computer interface space is Synchron, in partnership with Nvidia, working on creating AI models from extensive brain data to enhance interface intuitiveness. The advancements made by Merge Labs and similar entities signify a significant step forward in the convergence of human cognition and artificial intelligence.
Source: WIRED